Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1 USD | +7.56% | +30.54% | -30.50% |
03-27 | Cantor Fitzgerald Trims Price Target on Lucid Diagnostics to $3 From $3.80, Maintains Overweight Rating | MT |
03-26 | Transcript : Lucid Diagnostics Inc., Q4 2023 Earnings Call, Mar 26, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-30.50% | 46.28M | |
+73.67% | 12.39B | |
-16.65% | 8.08B | |
+17.40% | 7.25B | |
+11.77% | 5.35B | |
+29.65% | 4.63B | |
-17.74% | 4.19B | |
-34.84% | 2.44B | |
+3.34% | 2.07B | |
+4.85% | 1.88B |
- Stock Market
- Equities
- LUCD Stock
- News Lucid Diagnostics Inc.
- Lucid Diagnostics : Prices IPO at $14 Per Share